Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Dr. Reddy's Laboratories Limited Company Profile (NYSE:RDY)

Consensus Ratings for Dr. Reddy's Laboratories Limited (NYSE:RDY) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $41.70 1.09% downside)

Analysts' Ratings History for Dr. Reddy's Laboratories Limited (NYSE:RDY)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/28/2014TheStreetUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
3/11/2014ZacksUpgradeNeutral -> Outperform$48.40ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
1/21/2014ZacksDowngradeOutperform -> Neutral$45.90ViewTweet This Rating  Share This Rating on StockTwits
12/23/2013ZacksUpgradeNeutral -> Outperform$43.90ViewTweet This Rating  Share This Rating on StockTwits
10/7/2013ZacksUpgradeUnderperform -> Neutral$39.90ViewTweet This Rating  Share This Rating on StockTwits
8/1/2013Jefferies GroupBoost Price Target$33.04 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2013ZacksDowngradeNeutral -> Underperform$35.60ViewTweet This Rating  Share This Rating on StockTwits
2/15/2013Citigroup Inc.Reiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
2/15/2013Bank of AmericaDowngradeBuy -> Neutral$36.72ViewTweet This Rating  Share This Rating on StockTwits
12/13/2012Credit SuisseUpgradeNeutral -> OutperformViewTweet This Rating  Share This Rating on StockTwits
11/30/2012Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
5/14/2012JPMorgan Chase & Co.UpgradeNeutral -> OverweightViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/18/2012 forward)